Image

Natural Course of Initially Metabolic Healthy Obese Individuals (Healthy Obesity)?

Natural Course of Initially Metabolic Healthy Obese Individuals (Healthy Obesity)?

Recruiting
18-60 years
All
Phase N/A

Powered by AI

Overview

The main goal of this study is to gain a thorough understanding, which specific factors drive the unhealthy sequelae of obesity. Therefore, the investigators want to understand:

  1. What distinguishes obese persons without metabolic diseases from those with medical diseases in a cross-sectional comparison?
  2. Which factors drive the conversions from metabolically healthy obesity into a metabolically unhealthy obesity in a longitudinal approach?

Description

The hypothesis is, that changes in the molecular regulation of adipose tissue as well as in adipose tissue cellular composition are responsible for the development of a rather metabolic healthy or unhealthy phenotype. Knowledge of these factors will be used to generate new diagnostic concepts for personalized risk prediction and will furthermore serve as the basis to develop novel strategies to target adipose tissue to improve metabolic health.

Eligibility

Inclusion Criteria:

  • Signed Informed Consent Form
  • Age between 18 and 60 years
  • BMI 30-50 kg/m2
  • Knowledge of German, which requires sufficient written and allow oral patient education

Inclusion criteria for initially healthy group

  • Blood pressure < 140/90 mmHg
  • Normal glucose metabolism
    • HbA1c < 6.5 %
    • Fasting Glucose < 7.0 mmol/l
  • Normal lipid metabolism
    • LDL-cholesterol < 5.0 mmol/l
  • ≤ 2 of the following metabolic syndrome criteria combined (excluding waist

    circumference)

  • TG > 1.7 mmol/l
  • HDL-cholesterol > 1.0 mmol/l (male) / > 1.3 mmol/l (female)
  • Fasting glucose ≥ 5.6 mmol/l
  • BP ≥ 130/85 mmHg

Exclusion Criteria:

  • Pregnancy
  • Medication and / or pathologies that prevent a safe execution of the fat tissue biopsies
  • History of or planned bariatric operation
  • Medical conditions that prevent examinations and testing (e.g. symptomatic cardiovascular diseases)
  • Active Malignant tumor (<2a remission)

Study details
    Healthy Obesity
    Metabolically

NCT06799897

ETH Zurich

7 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.